Company Filing History:
Years Active: 2011-2014
Title: Gregory D Ferguson: Innovator in Immunomodulatory Drug Activity
Introduction
Gregory D Ferguson is a notable inventor based in San Diego, CA. He has made significant contributions to the field of immunomodulatory drug activity, holding a total of 3 patents. His work focuses on the use of micro-RNA as biomarkers, which has implications for patient treatment and compliance.
Latest Patents
Ferguson's latest patents include innovative methods for determining the activity of immunomodulatory compounds. One of his patents discusses the use of micro-RNA as a biomarker of immunomodulatory drug activity. This patent outlines methods for assessing the presence of miRNA in samples, which can help evaluate patient compliance with treatment. Another patent involves aminotriazolopyridines, detailing heteroaryl compounds and their applications in treatment methods.
Career Highlights
Throughout his career, Gregory D Ferguson has worked with prominent companies in the pharmaceutical industry. He has been associated with Celgene Corporation and Signal Pharmaceuticals, Inc., where he contributed to advancements in drug development and research.
Collaborations
Ferguson has collaborated with notable colleagues, including Helen A Brady and Kyle Chan, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Gregory D Ferguson's innovative work in immunomodulatory drug activity and his contributions to the field through his patents highlight his role as a significant inventor. His research continues to influence the development of new therapeutic strategies.